Pigmentation is a skin condition caused by high quantities of melanin, a substance in the body that produces hair, eye, and skin pigmentation. Skin pigmentation disorders affect the color of the skin. Some common types of skin pigmentation disorders are albinism, melasma, vitiligo, and pigment changes from skin damage. Thus, with the rise in prevalence of pigmentation disorders, demand for safe and effective treatment is also increasing rapidly.
Market Dynamics:
Increase in prevalence of pigmentation disorders, growing geriatric population worldwide, rise in demand for safe and effective treatment, increasing awareness among people about pigmentation disorders, and increase in focus on the development of novel treatments are major factors expected to propel growth of the global pigmentation disorders treatment market.
For instance, in July 2022, the U.S. Food and Drug Administration (USFDA) approved ruxolitinib (Opzelura) cream 1.5 percent as a treatment for the most common form of vitiligo, according to a statement by Incyte, the manufacturer of the drug.
Moreover, in October 2021, Uniza Healthcare announced the launched of a novel treatment for the management of Vitiligo in Indian Market. Vitellus is a novel combination of Greyverse, Melitane, GL 200, & EUK-134 which is an advanced new age solution for management of Vitiligo. Vitellus lotion is a 3 in 1 solution and helps in growth of melamine and works on skin pigmentation, hair follicle pigmentation and also as a super antioxidant.
Key features of the study:
- This report provides in-depth analysis of the global pigmentation disorders treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global pigmentation disorders treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Abbvie Inc. (Allergan Inc.), Episciences Inc., L'OREAL SA (SkinCeuticals International), and Pfizer Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global pigmentation disorders treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pigmentation disorders treatment market.
Detailed Segmentation:
- Global Pigmentation Disorders Treatment Market, By Type of Disorder:
- Albinism
- Vitiligo
- Melasma
- Post-Inflammatory Hyperpigmentation (PIH)
- Other Types of Disorders
- Global Pigmentation Disorders Treatment Market, By Treatment Type:
- Topical Treatment
- Dermabrasion
- Chemical peels
- Laser Treatment
- Phototherapy
- Other Treatment Types
- Global Pigmentation Disorders Treatment Market, By Geography:
- North America
- Europe
- Asia-Pacific
- Middle East and Africa
- South America
- Company Profiles:
- Abbvie Inc. (Allergan Inc.)
- Episciences Inc.
- L'OREAL SA (SkinCeuticals International)
- Pfizer Inc.